28 related articles for article (PubMed ID: 3871117)
1. Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma.
Mathiot C; Teillaud JL; Elmalek M; Mosseri V; Euller-Ziegler L; Daragon A; Grosbois B; Michaux JL; Facon T; Bernard JF
J Clin Immunol; 1993 Jan; 13(1):41-8. PubMed ID: 8445043
[TBL] [Abstract][Full Text] [Related]
2. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD.
Rudd PM; Fortune F; Patel T; Parekh RB; Dwek RA; Lehner T
Immunology; 1994 Sep; 83(1):99-106. PubMed ID: 7821975
[TBL] [Abstract][Full Text] [Related]
3. Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.
Hoover RG; Lary C; Page R; Travis P; Owens R; Flick J; Kornbluth J; Barlogie B
J Clin Invest; 1995 Jan; 95(1):241-7. PubMed ID: 7529259
[TBL] [Abstract][Full Text] [Related]
4. Binding of human IgA1 to rat peritoneal macrophages.
Gorter A; Hiemstra PS; van der Voort EA; van Es LA; Daha MR
Immunology; 1988 Jun; 64(2):207-12. PubMed ID: 3391640
[TBL] [Abstract][Full Text] [Related]
5. Regulation of IgA synthesis and immune response by T cells and interleukins.
McGhee JR; Mestecky J; Elson CO; Kiyono H
J Clin Immunol; 1989 May; 9(3):175-99. PubMed ID: 2671008
[No Abstract] [Full Text] [Related]
6. In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.
Mathiot C; Amigorena S; Moncuit J; Sautès C; Fridman WH; Teillaud JL
Immunol Res; 1992; 11(3-4):296-304. PubMed ID: 1287123
[TBL] [Abstract][Full Text] [Related]
7. Regulation of IgA expression by isotype-specific T cells and soluble binding factors.
Word CJ; Crago SS; Tomasi TB
Annu Rev Microbiol; 1986; 40():503-24. PubMed ID: 3535651
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulation of murine and human myeloma.
Hoover RG; Kornbluth J
Hematol Oncol Clin North Am; 1992 Apr; 6(2):407-24. PubMed ID: 1582982
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte surface membrane immunoglobulin in myeloma. II. T cells with IgA-Fc receptors are markedly increased in mice with IgA plasmacytomas.
Hoover RG; Lynch RG
J Immunol; 1980 Sep; 125(3):1280-8. PubMed ID: 6967897
[TBL] [Abstract][Full Text] [Related]
10. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
Mathur A; Lynch RG
J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of lymphocyte Fc alpha receptor in selective IgA deficiency and IgA nephropathy.
Adachi M; Yodoi J; Masuda T; Takatsuki K; Uchino H
J Immunol; 1983 Sep; 131(3):1246-51. PubMed ID: 6224855
[TBL] [Abstract][Full Text] [Related]
12. T cells with Fc receptors for IgA: induction of T alpha cells in vivo and in vitro by purified IgA.
Hoover RG; Dieckgraefe BK; Lynch RG
J Immunol; 1981 Oct; 127(4):1560-3. PubMed ID: 6974197
[TBL] [Abstract][Full Text] [Related]
13. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
[TBL] [Abstract][Full Text] [Related]
14. T cells with FC receptors in myeloma; suppression of growth and secretion of MOPC-315 by T alpha cells.
Müller S; Hoover RG
J Immunol; 1985 Jan; 134(1):644-7. PubMed ID: 3871117
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
